MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, FRA:H5O, ASX:MXC) Roby Zomer joins Proactive London's Katie Pilbeam to explain how the approval for sale in the European Union of ArtemiC will impact company.
The firm has been granted a certificate of free sale in Germany which Zomer explains will open up doors to sales in the EU and other international markets.
He says the Free Trade Certificate for ArtemiC Rescue and the ArtemiC product line in Germany, is a significant step forward for MGC Pharma as it opens the EU to the marketing and sale of one of the company's leading products.
